Promimic AB (publ) manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets. It offers HAnano surface technology that combines various properties that are known to improve osseointegration into one unique surface modification. The company was incorporated in 2004 and is headquartered in Mölndal, Sweden.
General Outlook
In simple terms, Promimic AB (publ) has 18.422 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 1.039% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.415%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.402%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust -0.127% return, is a testament to Promimic AB (publ)'s adeptness in optimizing resource deployment. Promimic AB (publ)'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.138%. Furthermore, the proficiency of Promimic AB (publ) in capital utilization is underscored by a remarkable -0.150% return on capital employed.
Stock Prices
Promimic AB (publ)'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $29, while its low point bottomed out at $28. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Promimic AB (publ)'s stock market.
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”